These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. New drug therapies and their effect on the skin. Treudler R J Dtsch Dermatol Ges; 2009 Jul; 7(7):623-37. PubMed ID: 19614812 [TBL] [Abstract][Full Text] [Related]
26. [Adverse cutaneous reactions to drugs in neurology]. Redondo Bellón P Rev Neurol; 1997 Sep; 25 Suppl 3():S309-19. PubMed ID: 9273176 [TBL] [Abstract][Full Text] [Related]
28. Allergic cutaneous reactions to drugs. Bigby M; Stern RS; Arndt KA Prim Care; 1989 Sep; 16(3):713-27. PubMed ID: 2529577 [TBL] [Abstract][Full Text] [Related]
29. [Cutaneous side effects of gold therapy. Clinical and histologic results]. Hofmann C; Burg G; Jung C Z Rheumatol; 1986; 45(3):100-6. PubMed ID: 2944308 [TBL] [Abstract][Full Text] [Related]
30. [Side-effects of beta-receptor blockaders on the skin]. Hödl S Z Hautkr; 1983 Jan; 58(1):17-28. PubMed ID: 6131557 [TBL] [Abstract][Full Text] [Related]
31. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review. Grinblat B; Scheinberg M Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718 [TBL] [Abstract][Full Text] [Related]
32. Histopathological and immunohistochemical features of drug-induced exanthems. Lisi P; Pelliccia S; Bellini V G Ital Dermatol Venereol; 2014 Apr; 149(2):237-41. PubMed ID: 24819645 [TBL] [Abstract][Full Text] [Related]
33. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. de Gannes GC; Ghoreishi M; Pope J; Russell A; Bell D; Adams S; Shojania K; Martinka M; Dutz JP Arch Dermatol; 2007 Feb; 143(2):223-31. PubMed ID: 17310002 [TBL] [Abstract][Full Text] [Related]
34. The usefulness of skin tests to prove drug hypersensitivity. Lammintausta K; Kortekangas-Savolainen O Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154 [TBL] [Abstract][Full Text] [Related]
35. [Lichenoid eruptions after gold therapy. Report of two cases]. Lasarowa AZ; Tsankov NK; Stoimenov AP Hautarzt; 1992 Aug; 43(8):514-6. PubMed ID: 1387122 [TBL] [Abstract][Full Text] [Related]
36. [The immune system of the skin and stereotyped reaction patterns in inflammatory skin diseases]. Jaspars EH Ned Tijdschr Geneeskd; 2006 Apr; 150(17):948-55. PubMed ID: 17225734 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous reactions to practolol. Clinical and histopathological study. Kauppinen K; Niemi KM; Salo OP Ann Clin Res; 1976 Aug; 8(4):232-40. PubMed ID: 136919 [TBL] [Abstract][Full Text] [Related]